Page 8 - Intrahepatic Cholangiocarcinoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail Cholangiocarcinoma (CCA) is considered as a diverse group of epithelial cancers characterized by poor outcomes. Cholangiocarcinoma can be divided into three types according to the original position: Intrahepatic Cholangiocarcinoma (ICC), Perihilar Cholangiocarcinoma (PCC) and Distal Extrahepatic Tumors (DET). The most promising way to cure cholangiocarcinoma is surgery, including laparoscopic liver resection and open liver resection. However, the post-surgical outcome is less than satisfactory and there is a poor 5-years survival rate of 16.5-48%. Furthermore, more than two-thirds of the patients are unable to be treated with surgery when diagnosed with cholangiocarcinoma. According to the present meta-analyses, HBV and HCV infections significantly increase the risk of cholangiocarcinoma. For instance, with the high HBV infection rates in Asia and China, the incidence rate of cholangiocarcinoma is approximately 7 per 1 million people in China. Unfortunately, there are no ef

Brain hospital of guangzhou medical universityIntrahepatic cholangiocarcinomaPerihilar cholangiocarcinomaDistal extrahepatic tumorsAffiliated brain hospitalGuangzhou medical universityAlbumin boundCalcium levofolinateமூளை மருத்துவமனை ஆஃப் குவாங்சோ மருத்துவ பல்கலைக்கழகம்இணைந்த மூளை மருத்துவமனைகுவாங்சோ மருத்துவ பல்கலைக்கழகம்